Table 2.
Hemodynamic and cerebrovascular responses during squat-stand maneuvers
No Intervention | Indomethacin | Hypocapnia | |
---|---|---|---|
Baseline, sitting | |||
Mean BP, mmHg | 84.1 ± 11.6 | 85.4 ± 13.5 | 81.3 ± 9.2 |
Mean MCAv, cm/s | 67.7 ± 10.6 | 45.5 ± 8.4* | 44.7 ± 7.1* |
MCA CVRi, mmHg·cm−1·s−1 | 1.3 ± 0.3 | 1.9 ± 0.4* | 1.9 ± 0.3* |
Mean PCAv, cm/s | 48.8 ± 10.2 | 33.6 ± 7.6* | 30.5 ± 9.6* |
PCA CVRi, mmHg·cm−1·s−1 | 1.8 ± 0.5 | 2.6 ± 0.7* | 2.9 ± 0.8* |
End tidal PCO2, mmHg | 41.4 ± 3.6 | 39.9 ± 3.7 | 25.5 ± 4.7*† |
Breathing frequency, per min | 13.8 ± 4.4 | 14.0 ± 3.8 | 26.4 ± 6.3*† |
Heart rate, bpm | 61.2 ± 9.8 | 52.6 ± 8.3 | 69.0 ± 12.5† |
Squat-stand, 0.05 Hz | |||
Mean BP, mmHg | 92.4 ± 13.0 | 91.4 ± 16.3 | 89.7 ± 11.9 |
Mean MCAv, cm/s | 59.9 ± 12.9 | 48.9 ± 9.7* | 48.3 ± 7.5* |
MCA CVRi, mmHg·cm−1·s−1 | 1.6 ± 0.4 | 1.9 ± 0.4* | 1.9 ± 0.3* |
Mean PCAv, cm/s | 45.4 ± 8.2 | 35.9 ± 8.1* | 32.4 ± 7.5* |
PCA CVRi, mmHg·cm−1·s−1 | 2.1 ± 0.4 | 2.6 ± 0.7* | 2.8 ± 0.7* |
End tidal PCO2, mmHg | 38.9 ± 3.2 | 37.7 ± 3.5 | 25.8 ± 4.3*† |
Breathing frequency, per min | 16.2 ± 4.5 | 17.5 ± 4.6 | 27.0 ± 7.0*† |
Heart rate, bpm | 86.3 ± 14.2 | 78.7 ± 12.5 | 84.5 ± 11.2 |
Squat-stand, 0.10 Hz | |||
Mean BP, mmHg | 93.3 ± 15.4 | 91.2 ± 12.1 | 89.7 ± 11.1 |
Mean MCAv, cm/s | 60.5 ± 13.8 | 50.0 ± 9.3* | 48.1 ± 7.4* |
MCAv CVRi, mmHg·cm−1·s−1 | 1.6 ± 0.4 | 1.9 ± 0.3* | 1.9 ± 0.3* |
Mean PCAv, cm/s | 44.9 ± 8.5 | 36.2 ± 7.0* | 33.1 ± 7.5* |
PCAv CVRi, mmHg·cm−1·s−1 | 2.1 ± 0.5 | 2.6 ± 0.6* | 2.7 ± 0.6* |
End tidal PCO2, mmHg | 39.6 ± 4.4 | 38.0 ± 4.3 | 25.5 ± 4.2*† |
Breathing frequency, per min | 17.0 ± 4.0 | 18.1 ± 5.0 | 28.7 ± 7.8*† |
Heart rate, bpm | 86.0 ± 12.9 | 79.0 ± 11.6 | 85.9 ± 11.2 |
Values are means ± SD.
BP, blood pressure; MCAv, middle cerebral artery velocity; PCAv, posterior cerebral artery velocity; CVRi, cerebrovascular resistance index; bpm, beats per minute.
Statistical significance was set at P < 0.05.
Significance from no intervention.
Significance from indomethacin intervention.